Mr. Eyal Schneid reports

SEEGNAL INC. ANNOUNCES EXTENSION OF MACCABI HEALTH SERVICES CONTRACT

Effective Sept. 8, 2025, Seegnal Inc. has amended its contract with Maccabi Health Services for an additional six years, and has also expanded the scope of the contract to include all of Maccabi's pharmacies and additional nurses. Maccabi is the second-largest health care management organization in Israel, serving over 2.6 million Israelis, and is renowned for its use of technology and emphasis on patient-centred care, according to Maccabi's website.

Pursuant to the amended agreement, Seegnal will continue to deliver its patented prescription co-pilot platform for an additional six years to Sept. 22, 2031, while expanding the scope to nurses and pharmacists in all of Maccabi's nationwide pharmacies. Maccabi is the first in Israel and one of the first HMOs worldwide to offer an end-to-end safety coverage throughout the patient journey, allowing complete visibility to pharmacists in the pharmacies into clinician decision while prescribing patient-centric medication. The expanded contract was changed from a fixed-base contract to Seegnal's current software-as-a-service-based model based on quarterly recurring licence fees and is expected to generate additional revenue for the corporation.

"This partnership is a testament to the measurable impact Seegnal delivers for health care providers who adopt a high patient-centric standard at the point of care over the traditional drug-to-drug interaction standard," said Eyal Schneid, chief executive officer of Seegnal. "We're proud to deepen our relationship with Maccabi Health Services and bring even greater precision, safety and efficiency to their clinical and operative workflows. This expansion also reinforces our strategic growth trajectory and positions us to scale our impact across broader markets."

Mr. Schneid added: "The new agreement extends through Sept. 22, 2031, with an option for Maccabi to extend it further by two years under the current terms. It broadens the integration beyond the electronic health record to the ERP system nationwide. It reflects growing demand for Seegnal's platform, which in a 2021 study published in the U.S. National Library of Medicine titled 'Comparison of Medication Alerts from Two Commercial Applications in the USA' demonstrated the ability to reduce alert load by up to 94 per cent, lower medication-related costs and improve clinician satisfaction -- key metrics that align with value-based care initiatives and payer priorities.

"Maccabi Health Services has been a partner in embracing customer-centric medication standards," added Mr. Schneid. "Together, we're setting a new standard for pro-active, patient-specific care. This milestone further validates our commercial strategy and underscores the scalability of our technology."

About Seegnal Inc.

Seegnal is a public company that aims to solve one of the top causes of death and injuries in the modern world: adverse drug effects. Seegnal's clinical decision support system introduces a paradigm shift in the approach to this problem by implementing a new elevated patient-centric standard. Seegnal's SaaS technology exclusively integrates at the point of care unique patient-specific data like genetics, results of lab tests, ECG, smoking, allergies, food, gender, age and the effects of many concomitant medications, while reducing the current alert load for clinicians by over 90 per cent. In practice, clinicians using Seegnal eHealth complete their prescription workflow with limited interruption, saving time and fatigue. Similarly, patients enjoy more tailored medication and improved safety, leading to better quality of life, due to the precision of alerts with up to 98-per-cent accuracy. Institutions reported a reduction in admissions, medication consumption and ample time savings in prescription renewals. Seegnal eHealth is marketing its SaaS-based platform in the state of Israel (where recently the Ministry of Health has adopted Seegnal's patient-specific standard as the new standard in governmental hospitals), the United Arab Emirates, the United Kingdom, the United States and Poland. The platform is currently a standard of care system for over 10,000 clinicians in Israel, used on a daily basis for prescribing medications to their patients.

We seek Safe Harbor.